Skip to content
CancerIndex

Ranking · Trials

Recruiting Phase III trials

Interventional studies with PHASE3 among their phases and overall status RECRUITING, mapped to this cancer or its descendants.

Computedci-phase3-recruiting-v1unit: counthigher = betterAll metrics

Top 15 by Recruiting Phase III trialsMalignant Lung Neoplasm179Malignant Breast Neoplasm150Non-Hodgkin Lymphoma115Leukemia99Malignant Prostate Neoplasm79Malignant Nasopharyngeal Neop…56Multiple Myeloma54Malignant Gastric Neoplasm49Malignant Liver Neoplasm46Malignant Ovarian Neoplasm46Malignant Pancreatic Neoplasm46Malignant Esophageal Neoplasm41Malignant Rectal Neoplasm36Malignant Cervical Neoplasm34Malignant Central Nervous Sys…27
RankΔCancerRecruiting Phase III trials (count)PercentileConfidenceSourcesWhy #n?
1=Malignant Lung Neoplasm179100High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
2644
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
179

ranking row 2569607

2=Malignant Breast Neoplasm15096.9High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
2627
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
150

ranking row 2569608

3=Non-Hodgkin Lymphoma11593.8High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
2168
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
115

ranking row 2569609

4=Leukemia9990.6High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
1769
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
99

ranking row 2569610

5=Malignant Prostate Neoplasm7987.5High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
1375
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
79

ranking row 2569611

6=Malignant Nasopharyngeal Neoplasm5684.4High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
261
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
56

ranking row 2569612

7=Multiple Myeloma5481.3High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
814
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
54

ranking row 2569613

8=Malignant Gastric Neoplasm4978.1High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
652
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
49

ranking row 2569614

9=Malignant Liver Neoplasm4675High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
906
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
46

ranking row 2569616

9=Malignant Ovarian Neoplasm4675High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
684
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
46

ranking row 2569617

9=Malignant Pancreatic Neoplasm4675High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
904
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
46

ranking row 2569615

12=Malignant Esophageal Neoplasm4165.6High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
518
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
41

ranking row 2569618

13=Malignant Rectal Neoplasm3662.5High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
386
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
36

ranking row 2569619

14=Malignant Cervical Neoplasm3459.4High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
505
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
34

ranking row 2569620

15=Malignant Central Nervous System Neoplasm2756.3High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
823
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
27

ranking row 2569621

16=Malignant Uterine Corpus Neoplasm2553.1High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
411
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
25

ranking row 2569622

17=Malignant Bladder Neoplasm2350High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
346
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
23

ranking row 2569623

18=Malignant Colon Neoplasm1846.9High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
225
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
18

ranking row 2569625

18=Malignant Kidney Neoplasm1846.9High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
453
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
18

ranking row 2569624

20=Malignant Thyroid Gland Neoplasm1240.6High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
176
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
12

ranking row 2569626

21=Malignant Lip and Oral Cavity Neoplasm1137.5High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
149
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
11

ranking row 2569627

22=Skin Carcinoma834.4High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
127
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
8

ranking row 2569628

23=Malignant Oropharyngeal Neoplasm731.3High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
143
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
7

ranking row 2569629

24=Hodgkin Lymphoma628.1High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
179
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
6

ranking row 2569630

25=Malignant Hypopharyngeal Neoplasm525High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
53
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
5

ranking row 2569632

25=Malignant Laryngeal Neoplasm525High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
66
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
5

ranking row 2569631

27=Cutaneous Melanoma318.8High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
78
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
3

ranking row 2569633

27=Malignant Testicular Neoplasm318.8High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
43
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
3

ranking row 2569634

29=Malignant Anal Neoplasm212.5High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
68
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
2

ranking row 2569636

29=Malignant Vaginal Neoplasm212.5High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
31
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
2

ranking row 2569635

31=Malignant Gallbladder Neoplasm16.3High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
32
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
1

ranking row 2569638

31=Malignant Mesothelioma16.3High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
96
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
1

ranking row 2569637

31=Malignant Vulvar Neoplasm16.3High confidenceclinicaltrials
inputs
asOf
2026-09-29
studyType
INTERVENTIONAL
aggregation
descendants
activeTrials
54
activeStatuses
  1. RECRUITING
  2. NOT_YET_RECRUITING
  3. ENROLLING_BY_INVITATION
  4. ACTIVE_NOT_RECRUITING
formulaVersion
ci-trial-intel-v1
phase3Recruiting
1

ranking row 2569639

Data updated 17 hours agoSource updated unknown33 eligible entities · inputs hash 284e53e9bc6e51772da0f4e8